Medium-vessel occlusions (MeVOs), that is, occlusions of the M2/3 middle cerebral artery,
A2/3 anterior cerebral artery, and P2/3 posterior cerebral artery segments, account for 25 …

Approximately one-third of acute ischemic strokes with an identifiable vessel occlusion are
caused by medium vessel occlusion (MeVO), that is, nonlarge vessel occlusions that are …

Background Evidence supporting a potential benefit of thrombectomy for distal medium
vessel occlusions (DMVOs) of the anterior cerebral artery (ACA) is, to the knowledge of the …

Background Recent progress with smaller retrievers has expanded the ability to reach distal
brain arteries. We herein report recanalization, bleeding complications and short-term …

Medium vessel occlusions (MeVOs, ie, M2, M3, A2, A3, P2, and P3 segment occlusions) are
increasingly recognized as a target for endovascular treatment in acute ischemic stroke. It is …

Aims Endovascular therapy (EVT) for distal medium vessel occlusions (DMVOs) is a
potential frontier of acute ischemic stroke (AIS) treatment, but its efficacy against best …

Introduction: First pass effect (FPE), achievement of complete recanalization (mTICI 2c/3)
with a single pass, is a significant predictor of favorable outcomes for endovascular …

Background As a meaningful subtype of ischemic stroke in Asians, Branch atheromatous
disease (BAD)-related stroke is associated with high early neurological deterioration (END) …

Endovascular thrombectomy (EVT) has been validated in several randomized controlled
trials in recent years for its efficacy in the treatment of acute ischemic strokes (AIS) and is …

Over the past few years, several randomized trials have proven the safety and efficacy of
endovascular treatment (EVT) in large vessel occlusion (LVO) stroke [1]. The stent retriever …